Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels.
J Obstet Gynaecol
; 43(1): 2204940, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37186893
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Ováricas
/
Neoplasias Peritoneales
/
ARN Largo no Codificante
/
Hipertermia Inducida
Idioma:
En
Revista:
J Obstet Gynaecol
Año:
2023
Tipo del documento:
Article